NHS Support and Excess Treatment Costs - NEW GUIDANCE ISSUED FOR RESEARCH STUDIES RECRUITING IN NORTHERN IRELAND
It is important that the costs of health and social care research in the United Kingdom are properly identified and appropriately funded by the right organisations. For this purpose, guidance on Attributing the costs of health and social care Research and Development (AcoRD) was introduced in 2012 (see below). The AcoRD guidance provides a framework for the NHS and its partners to identify, attribute and recover the various costs associated with research in the NHS, in a transparent, robust and consistent manner. It applies to all NHS* research covered by the UK Policy Framework for Health and Social Care, and most funders will ask applicant to identify and attribute costs in line with the guidance.
New guidance and processes have been implemented for funding and approving Excess Treatment Costs and Service Support Costs associated with research that proposes to recruit participants through the NHS or an organisation providing a service on behalf of the NHS. The guidance for accessing funding for these costs for studies recruiting participants through a health and social care (HSC) organisation in Northern Ireland, or an organisation commissioned to provide services on behalf of the HSC, is available here. Further information about the processes in other areas of the UK can be found in the country-specific guidance (England; Wales; Scotland).
Attributing the costs of health and social care Research & Development (AcoRD)
In May 2012, the Department of Health (DH) published new guidance, entitled “Attributing the costs of health and social care Research and Development” (AcoRD) to provide a framework for the NHS and its partners to identify, attribute and recover the various costs associated with research in the NHS, in a transparent, robust and consistent manner. AcoRD also provides a new mechanism to meet some of the costs of high quality peer reviewed charity-funded research in the HSC. It recognises the important contribution research charities make to the HSC research environment, funding research through donations made by patients and the public. For this reason, the AcoRD guidance identifies some research costs (Annex A Part B) that would be funded by DH either via NIHR CRN or through Research Capability Funding for studies funded by members of the Association of Medical Research Charities (AMRC).
The key purpose of the AcoRD guidance is to:
- Improve the consistency of cost attribution
- Encourage more consistent funding of the costs of research
HSC R&D Division has published AcoRD guidelines for Northern Ireland. These are based on the same principles as the DH publication but reflect the differences in infrastructure and funding arrangements in Northern Ireland. While drawing on well-established attribution principles, the release of the AcoRD guidance in Northern Ireland is an important step forward in clarifying the principles for attributing the costs of HSC research.
AcoRD provides a framework for the identification, attribution and, where relevant, recovery of the various costs associated with research in the HSC, in a transparent, robust and consistent manner. Clarification is provided between the three categories of costs associated with non-commercial research studies:
- Research Costs
- HSC Support Costs
- HSC Treatment Costs
The AcoRD guidance and two associated Annexes are available at the links below for your information. Annex A provides an exemplar set of common activities that have been attributed to the three specific cost categories and Annex B provides a list of Frequently Asked Questions (FAQs). These Annexes will be updated as required and users should ensure that they refer to the latest version when attributing the costs of research.
AcoRD guidance-Northern Ireland.pdf
AcoRD - Annex A-Northern Ireland.pdf
AcoRD - Annex B-Northern Ireland.pdf
To access the DHSC AcoRD documentation, click here.